Contraception
Mifepristone enhances glandular androgen receptor expression
Published in Women's Health Weekly, July 8th, 2004
According to recent research from Scotland, "Mifepristone in daily low doses has contraceptive potential by inhibiting ovulation. Follicular development is maintained, and although the endometrium is exposed to unopposed estrogen, there are no signs of hyperplasia or atypia. The mechanism of this anti-estrogenic action is unknown.
"We have investigated the effect of daily low-dose mifepristone on proliferation markers and steroid receptors in surface epithelium, glands, and stroma of the endometrium," reported N....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Assisted Reproduction
ART can't compensate for waiting too long to start a family - Breast Cancer
Study offers new target to stop cancer growth - Endocrinology
Animal study reveals negative adrenocortical effects of long-term estrogen - Hormone Replacement Therapy
New study finds estrogen use doesn't reduce dementia risk in older women - Polycystic Ovary Syndrome
Study finds rosiglitazone a "promising, well-tolerated" treatment for PCOS - Adrenal Incidentaloma
Female AI patients with hypercortisolism are at risk for low spinal BMD - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
